AONN+ Statement About COVID-19

Press Releases published on March 13, 2020 in News & Updates, COVID-19

AONN+ Position COVID-19

In light of the COVID-19 novel coronavirus, the Academy of Oncology Nurse & Patient Navigators (AONN+) is aware of the increased acuity of patient care that navigators are managing on a daily basis with patients with cancer and their families. In response, we aim to support our professional members with credible resources/information they can use to educate and empower those around them as well as alleviate fears. The navigator’s primary responsibility to the patient is to follow the mandatory guidelines set by their federal, state, and/or healthcare institution.

Patient Empowerment

Patient empowerment is a key competency skill for all navigators and is reflected in AONN+ knowledge domains as well as the National Navigation Roundtable competency domains. As discussions are held with patients with cancer, their families, and other community members, it is critical to apply insight and understanding about emotions, and human responses to emotions, to create and maintain positive interpersonal interactions. Please demonstrate interpersonal and communication skills that result in the effective exchange of information and collaboration across the broad range of socioeconomic and cultural backgrounds encountered daily.

A Message From AONN+ Program Director Sharon Gentry

A message from our Program Director Sharon Gentry to the AONN+ community and all the healthcare workers working tirelessly to save lives during the COVID-19 outbreak.

View Our COVID-19 Navigator Toolkit Read FAQs on CONQUER

Related Items
AONN+'s ER+ Premenopausal Breast Cancer Journey Pathway Wins PM360 Pharma Choice Award
Press Releases published on February 28, 2024 in News & Updates
Cranbury, NJ (February 28, 2024)—The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to share that PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostic industries, has named AONN+’s estrogen-receptor-positive (ER+) Premenopausal Breast Cancer Journey Pathway, supported by TerSera Therapeutics, as the Pharma Choice Award – Variety Silver Winner.
The Academy of Oncology Nurse & Patient Navigators (AONN+) Selects Sites to Participate in National Acuity Quality Initiative
Press Releases published on October 4, 2023 in News & Updates
CRANBURY, NJ (Oct. 4, 2023) – The Academy of Oncology Nurse & Patient Navigators’ (AONN+) National Navigation Acuity Taskforce is developing a standardized, validated, evidence-based Navigation Acuity Tool for oncology navigation programs. When finalized, the acuity tool is expected to help oncology navigators characterize the intensity of the patient navigation workload, aid in the allocation of resources, and measure the effectiveness of navigation on patient outcomes.
The Academy of Oncology Nurse & Patient Navigators (AONN+) Announces New Leadership Council Members
Press Releases published on August 16, 2023 in News & Updates
CRANBURY, NJ—Each year, the AONN+ Leadership Council strives to bring novel ideas and perspectives to the table through the addition of new members.